US bill to strengthen FDA’s foreign safety programme stalled
This article was originally published in SRA
Executive Summary
Draft US legislation that would provide the US Food and Drug Administration with increased funding to ensure the safety of drugs and medical devices in “a global marketplace” appears to have been put on the back burner.